PALATIN TECHNOLOGIES, INC. Proceeds from Sale of Available-for-sale Securities
PALATIN TECHNOLOGIES, INC. (PTN) reported Proceeds from Sale of Available-for-sale Securities of $3.44 million for the 12-month period ending 2011-06-30, per its 10-K filed 2012-09-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2012-09-10
- PALATIN TECHNOLOGIES, INC. proceeds from sale of available-for-sale securities for the quarter ending 2011-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. proceeds from sale of available-for-sale securities for the quarter ending 2011-03-31 was $1.94M.
- PALATIN TECHNOLOGIES, INC. proceeds from sale of available-for-sale securities for fiscal 2011 was $3.44M.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-10 | $1.94M derived: sum of 2 quarters · filed 2012-09-10 | $3.44M 10-K · filed 2012-09-10 | |
| 2011-03-31 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | $3.44M 10-Q · filed 2012-05-14 | ||
| 2010-12-31 | $1.50M 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |